captopril has been researched along with 2-pyrazinoylguanidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beyer, KH; Follansbee, MH; Griffith, JW; Vesell, ES | 1 |
| Beyer, KH; Follansbee, MH; Vesell, ES | 1 |
2 other study(ies) available for captopril and 2-pyrazinoylguanidine
| Article | Year |
|---|---|
Studies on pyrazinoylguanidine. 5. Temporal effects over 24 weeks demonstrating attenuation of diabetic nephropathy in STZ-diabetic rats.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Guanidines; Hydrochlorothiazide; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Kidney; Kidney Function Tests; Male; Molecular Weight; Pyrazines; Rats; Rats, Sprague-Dawley; Serum Albumin; Streptozocin | 1997 |
Studies on pyrazinoylguanidine. 6. Prevention of cataracts in STZ-diabetic rats.
Topics: Animals; Antihypertensive Agents; Captopril; Cataract; Diabetes Mellitus, Experimental; Guanidines; Hypoglycemic Agents; Male; Odds Ratio; Pyrazines; Rats; Rats, Sprague-Dawley; Streptozocin | 1997 |